Skip to main content
Erschienen in: HNO 6/2019

08.04.2019 | Schwindel | Leitthema

Vestibular migraine treatment and prevention

verfasst von: Dr. A. Lapira, MD, MA, MSc, DLORCS, AuD, FAAA

Erschienen in: HNO | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Vestibular migraine probably represents the second most common cause of vertigo after benign positional vertigo, by far exceeding Ménière disease. There are still relatively few published reports on vestibular migraine management, despite its enormous importance in daily practice. In 2003 the first clinical definition of vestibular migraine was proposed. Studies published before 2003 used variable terms for vestibular migraine. Some authors recommend treating vestibular migraine using multiple drugs; others have focused on using only one drug. Although at present it is not possible to quantify the effects of the treatments proposed, some recommendations can be made.
Literatur
1.
Zurück zum Zitat Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular vertigo. J Neurol 256:333–338CrossRefPubMed Lempert T, Neuhauser H (2009) Epidemiology of vertigo, migraine and vestibular vertigo. J Neurol 256:333–338CrossRefPubMed
2.
Zurück zum Zitat Furman JM, Marcus DA, Balaban CD (2003) Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16:5–13CrossRefPubMed Furman JM, Marcus DA, Balaban CD (2003) Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16:5–13CrossRefPubMed
3.
Zurück zum Zitat Ménière P (1861) Memoire sur des lesions de loreille interne donnant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med 16:597–601 Ménière P (1861) Memoire sur des lesions de loreille interne donnant lieu a des symptomes de congestion cerebrale apoplectiforme. Gaz Med 16:597–601
5.
Zurück zum Zitat Graham JR (1968) Migraine: clinical aspects. In: Vinken PJ, Bruin GW (eds) Handbook of clinical neurology, 1st edn. North-Holland, Amsterdam, pp 45–58 Graham JR (1968) Migraine: clinical aspects. In: Vinken PJ, Bruin GW (eds) Handbook of clinical neurology, 1st edn. North-Holland, Amsterdam, pp 45–58
6.
7.
Zurück zum Zitat Neuhauser HK, Radtke A, von Brevern M et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Baillieres Clin Neurol 67(6):1028–1033 Neuhauser HK, Radtke A, von Brevern M et al (2006) Migrainous vertigo: prevalence and impact on quality of life. Baillieres Clin Neurol 67(6):1028–1033
9.
Zurück zum Zitat Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzja A, Budisic M, Demarin V (2007) Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 47:1427–1435CrossRefPubMed Vukovic V, Plavec D, Galinovic I, Lovrencic-Huzja A, Budisic M, Demarin V (2007) Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 47:1427–1435CrossRefPubMed
10.
Zurück zum Zitat Neuhauser H, Lempert T (2004) Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalgia 24:83–91CrossRef Neuhauser H, Lempert T (2004) Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalgia 24:83–91CrossRef
11.
Zurück zum Zitat von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T (2005) Acute migrainous vertigo: clinical and oculographic findings. Brain 128:365–374CrossRef von Brevern M, Zeise D, Neuhauser H, Clarke AH, Lempert T (2005) Acute migrainous vertigo: clinical and oculographic findings. Brain 128:365–374CrossRef
14.
Zurück zum Zitat Goadsby PJ (2009) The vascular theory of migraine—a great story wrecked by the facts. Brain 132:6–7CrossRefPubMed Goadsby PJ (2009) The vascular theory of migraine—a great story wrecked by the facts. Brain 132:6–7CrossRefPubMed
15.
Zurück zum Zitat Russo A, Marcelli V, Esposito F et al (2014) Abnormal thalamic function in patients with vestibular migraine. Baillieres Clin Neurol 82(23):2120–2126 Russo A, Marcelli V, Esposito F et al (2014) Abnormal thalamic function in patients with vestibular migraine. Baillieres Clin Neurol 82(23):2120–2126
16.
Zurück zum Zitat Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341CrossRefPubMed Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009) Neurobiology of migraine. Neuroscience 161:327–341CrossRefPubMed
17.
Zurück zum Zitat Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Baillieres Clin Neurol 62:17–22 Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Baillieres Clin Neurol 62:17–22
18.
Zurück zum Zitat Lee H, Jen JC, Wang H et al (2006) A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet 15(2):251–258CrossRefPubMed Lee H, Jen JC, Wang H et al (2006) A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet 15(2):251–258CrossRefPubMed
19.
Zurück zum Zitat Lee H, Sininger L, Jen JC et al (2007) Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 8(3):195–200CrossRefPubMed Lee H, Sininger L, Jen JC et al (2007) Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 8(3):195–200CrossRefPubMed
20.
Zurück zum Zitat Furman JM, Marcus DA, Balaban CD (2013) Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 12(7):706–715CrossRefPubMed Furman JM, Marcus DA, Balaban CD (2013) Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol 12(7):706–715CrossRefPubMed
21.
Zurück zum Zitat Neuhauser H, Leopold HM, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Baillieres Clin Neurol 56:436–441 Neuhauser H, Leopold HM, von Brevern M, Arnold G, Lempert T (2001) The interrelations of migraine, vertigo, and migrainous vertigo. Baillieres Clin Neurol 56:436–441
22.
Zurück zum Zitat International Headache Soxiety (2018) The international classification of headache disorders, 3rd edition [beta version]. Cephalgia 38(1):1–211CrossRef International Headache Soxiety (2018) The international classification of headache disorders, 3rd edition [beta version]. Cephalgia 38(1):1–211CrossRef
23.
Zurück zum Zitat Olsson JE (1991) Neurotologic findings in basilar migraine. Laryngoscope 101(Suppl 52):1–41CrossRefPubMed Olsson JE (1991) Neurotologic findings in basilar migraine. Laryngoscope 101(Suppl 52):1–41CrossRefPubMed
24.
Zurück zum Zitat Celebisoy N, Gokcay F, Sirin H et al (2008) Migrainous vertigo: clincal, oculographic and posturographic findings. Cephalgia 28(1):72–77CrossRef Celebisoy N, Gokcay F, Sirin H et al (2008) Migrainous vertigo: clincal, oculographic and posturographic findings. Cephalgia 28(1):72–77CrossRef
25.
Zurück zum Zitat Rang HP, Dale MM, Ritter JM, Moore PK (2003) Pharmacology. Elsevier, Bath Rang HP, Dale MM, Ritter JM, Moore PK (2003) Pharmacology. Elsevier, Bath
26.
Zurück zum Zitat Tusa RJ (1999) Diagnosis and management of neuro-otological disorders due to migraine. In: Herdmann SJ (ed) Vestibular rehabilitation. FA Davis, Philadelphia, pp 298–315 Tusa RJ (1999) Diagnosis and management of neuro-otological disorders due to migraine. In: Herdmann SJ (ed) Vestibular rehabilitation. FA Davis, Philadelphia, pp 298–315
27.
Zurück zum Zitat Olesen J (1988) Calcium entry blockers in the treatment of vertigo. Ann N Y Acad Sci 522:690–697CrossRefPubMed Olesen J (1988) Calcium entry blockers in the treatment of vertigo. Ann N Y Acad Sci 522:690–697CrossRefPubMed
28.
Zurück zum Zitat Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 23:364–371CrossRefPubMed Reploeg MD, Goebel JA (2002) Migraine-associated dizziness: Patient characteristics and management options. Otol Neurotol 23:364–371CrossRefPubMed
29.
30.
Zurück zum Zitat Furman JM, Balaban CD, Jacob RG, Marcus DA (2005) Migraine–anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 76:1–8CrossRefPubMedPubMedCentral Furman JM, Balaban CD, Jacob RG, Marcus DA (2005) Migraine–anxiety related dizziness (MARD): a new disorder? J Neurol Neurosurg Psychiatry 76:1–8CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G et al (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123:588–593CrossRefPubMed Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G et al (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Otolaryngol 123:588–593CrossRefPubMed
32.
Zurück zum Zitat Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolaryngol Suppl 490:1–10CrossRefPubMed Fraysse B, Bebear JP, Dubreuil C, Berges C, Dauman R (1991) Betahistine dihydrochloride versus flunarizine. A double-blind study on recurrent vertigo with or without cochlear syndrome typical of Menière’s disease. Acta Otolaryngol Suppl 490:1–10CrossRefPubMed
33.
Zurück zum Zitat Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V et al (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. J Neurol 249:206–211CrossRefPubMed Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V et al (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: A randomised placebo-controlled trial. J Neurol 249:206–211CrossRefPubMed
Metadaten
Titel
Vestibular migraine treatment and prevention
verfasst von
Dr. A. Lapira, MD, MA, MSc, DLORCS, AuD, FAAA
Publikationsdatum
08.04.2019
Verlag
Springer Medizin
Erschienen in
HNO / Ausgabe 6/2019
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI
https://doi.org/10.1007/s00106-019-0661-3

Weitere Artikel der Ausgabe 6/2019

HNO 6/2019 Zur Ausgabe

Update HNO

Allergologie

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.